| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/04/2005 | US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction |
| 01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | CA2332406C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040266875 Method for treatment and/or prophylaxis |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors |
| 12/29/2004 | WO2004113305A2 Diamino substituted quinazoline derivatives as promoters of smn2 |
| 12/29/2004 | WO2004112811A1 Eye-rinse solution made of grape juice |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
| 12/29/2004 | EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors |
| 12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
| 12/29/2004 | EP1491531A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/29/2004 | EP1491207A1 Novel screening method |
| 12/29/2004 | EP1491205A1 Remedy for hypermyotonia |
| 12/29/2004 | EP1491194A1 Vdac regulator |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 12/29/2004 | EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 12/29/2004 | EP1490363A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 12/29/2004 | EP1490357A1 Stable hydrate of a muscarinic receptor antagonist |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490324A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 12/29/2004 | EP1490119A1 Tissue treatment |
| 12/29/2004 | EP1490071A2 Theraputic methods and uses of sapogenins and their derivatives |
| 12/29/2004 | EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components |
| 12/29/2004 | EP1489915A1 Treatment and prevention of inflammatory disorders |
| 12/29/2004 | EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 12/29/2004 | EP1135123B1 Use of isatin derivatives as ion channel activating agents |
| 12/29/2004 | EP0967892B1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 12/29/2004 | CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell |
| 12/29/2004 | CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 12/29/2004 | CN1557375A Medicinal composition for treating amyotrophy |
| 12/29/2004 | CN1182247C Sequence-specific DNA recombination in eukaryotic cells |
| 12/29/2004 | CN1181842C Aseptic necrosis of head of femur treating traditional Chinese medicine pills |
| 12/28/2004 | US6835751 Bicyclic amino acids as pharmaceutical agents |
| 12/28/2004 | US6835732 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
| 12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
| 12/23/2004 | WO2004111068A1 Colchicoside analogues |
| 12/23/2004 | WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
| 12/23/2004 | WO2003082198A3 Methods of treatment with lxr modulators |
| 12/23/2004 | WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 12/23/2004 | US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 12/23/2004 | US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis |
| 12/23/2004 | US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents |
| 12/23/2004 | US20040259820 Kit for delivering decitabine in vivo |
| 12/23/2004 | US20040259779 Novel neurotrophic factors |
| 12/23/2004 | US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants |
| 12/23/2004 | CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases |
| 12/22/2004 | EP1489171A1 Functional molecule and process for producing the same |
| 12/22/2004 | EP1489076A1 Cyclic hemiacetal derivative and use thereof |
| 12/22/2004 | EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders |
| 12/22/2004 | EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 12/22/2004 | EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 12/22/2004 | EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same |
| 12/22/2004 | EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 12/22/2004 | EP1487835A1 Amides of acetic and propionic acids |
| 12/22/2004 | EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt |
| 12/22/2004 | EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 12/22/2004 | EP1487805A1 Pyrimidine derivatives |
| 12/22/2004 | EP1487800A1 Phenanthridinones as parp inhibitors |
| 12/22/2004 | EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/22/2004 | EP1487778A1 Substituted 4-aminocyclohexanols |
| 12/22/2004 | EP1487541A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 12/22/2004 | EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 12/22/2004 | EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto |
| 12/22/2004 | EP1453949A4 Production of cell suspensions |
| 12/22/2004 | CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 12/22/2004 | CN1556805A Piperidine derivative as NMDA receptor antagonist |
| 12/22/2004 | CN1556716A Modular infusion device and method |
| 12/22/2004 | CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors |
| 12/22/2004 | CN1181059C Quinoline-4-base derivative I |
| 12/22/2004 | CN1180802C Medicine for external application for curing traumatic injury |
| 12/21/2004 | US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects |
| 12/16/2004 | WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 12/16/2004 | WO2004108157A2 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |